THESEUS PHARMACEUTICALS, INC. Proceeds from Issuance Initial Public Offering
THESEUS PHARMACEUTICALS, INC. reported Proceeds from Issuance Initial Public Offering of $166.24 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2023-03-09
- THESEUS PHARMACEUTICALS, INC. proceeds from issuance initial public offering for fiscal 2021 was $166.24M.
| Period end | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|
| 2021-12-31 | $166.24M 10-K · filed 2023-03-09 |